Chronic treatment with losartan and carvedilol differentially modulates renal vascular responses to sympathomimetics compared to treatment with individual agents in normal Wistar Kyoto and spontaneously hypertensive rats

European Journal of Pharmacology

Volumn 612, Issue 1-3, 2009, Pages 69-74

  Abdulla, Mohammed H ^a   Sattar, Munavvar A ^a   Abdullah, Nor A ^b   Khan, Md Abdul H ^c   AbdAllah, H H ^d   Johns, Edward J ^e  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SCHOOL OF PHYSICS   (Malaysia)

^e UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

1 Adrenoceptors; Carvedilol; Isoprenaline; Losartan; Spontaneously hypertensive rat

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; CARVEDILOL; DOPAMINE; ISOPRENALINE; LOSARTAN; LOSARTAN POTASSIUM; PHENYLEPHRINE;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEART RATE; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; VASOCONSTRICTION; WISTAR KYOTO RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARBAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HEART RATE; KIDNEY; LOSARTAN; MALE; PROPANOLAMINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REGIONAL BLOOD FLOW; SYMPATHOMIMETICS; TIME FACTORS;

EID: 65549111392     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.064     Document Type: Article

References (42)

1. Abdulla M.H., Sattar M.A., Salman I.M., Abdullah N.A., Ameer O.Z., Khan Md A.H., and Johns E.J. Effect of acute unilateral renal denervation on renal hemodynamics in spontaneously hypertensive rats. J. Auton. Autacoid Pharmacol. 28 (2008) 87-94
2. Abdulla M.H., Sattar M.A., Abdullah N.A., Hazim A.I., Anand Swarup K.R.L., Rathore H.A., Khan Md A.H., and Johns E.J. Inhibition of Ang II and renal sympathetic nerve influence dopamine and isoprenaline induced renal hemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats. J. Auton. Autacoid Pharmacol. 28 (2008) 95-101
3. 1receptor blockade on angiotensin II and adrenergic agonists-induced renal vasoconstrictions in spontaneously hypertensive rats. Acta Physiol. (Oxf.) 195 (2009) 397-404
4. Abdul Sattar M., and Johns E.J. Alpha 1-adrenoceptor subtypes mediating adrenergic vasoconstriction in kidney, one-clip Goldblatt and deoxycorticosterone acetate-salt hypertensive rats. J. Cardiovasc. Pharmacol. 24 (1994) 420-428
5. Armenia A., Munavvar A.S., Abdulla N.A., Helmi A., and Johns E.J. The contribution of adrenoceptor subtype(s) in the renal vasculature of diabetic spontaneously hypertensive rats. Br. J. Pharmacol. 142 (2004) 719-726
6. Augustin H.J., Baumgarten H.G., Huland H., and Leichtweiß H.-P. The vasoconstrictive effect of dopamine in the isolated, perfused rat kidney after catecholamine depletion. Res. Exp. Med. 170 (1977) 1-15
7. Balt J.C., Mathy M.J., Pfaffendorf M., and van Zwieten P.A. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats. Fund. Clin. Pharmacol. 17 (2003) 83-91
8. Bayorh M.A., Ganafa A.A., Eatman D., Walton M., and Feuerstein G.Z. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am. J. Hypertens. 18 (2005) 1496-1502
9. Bayorh M.A., Layas M.F., Mann G., Feuerstein G.Z., and Eatman D. The effect of diet on simvastatin and losartan enhancement of endothelial function. Clin. Exp. Hypertens. 29 (2007) 311-325
10. Biovin V., Jahns R., Gambaryan S., Ness W., Boege F., and Lohse M.J. Immunofluorescent imaging of beta 1- and beta 2-adrenergic receptors in rat kidney. Kidney Int. 59 (2001) 515-531
11. Chapman B.J., Horn N.M., Munday K.A., and Robertson M.J. The actions of dopamine and of sulpiride on regional blood flows in the rat kidney. J. Physiol. 298 (1980) 437-452
12. 1-adrenergic receptor research. Acta Pharmacol. Sin. 26 (2005) 1-7
13. Clough D., Hatton R., Keddie J., and Collis M. Hypotensive action of captopril in spontaneously hypertensive and normotensive rats. Interference with neurogenic vasoconstriction. Hypertension 4 (1982) 764-772
14. Crespo M.J. Interaction between AT1 and a1-adrenergic receptors in cardiomyopathic hamsters. J. Card. Fail. 6 (2000) 257-263
15. de Jonge A., Knape J., van Meel J., Kalkman H.O., Wilffert B., Thoolen M.J., Timmermanns P.B., and van Zwieten P.A. Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1- and alpha 2-adrenoceptor stimulation in pithed normotensive rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 321 (1982) 309-313
16. Dupont A.G. Carvedilol and the kidney. Clin. Investig. 70 (1992) S127-S131
17. Feuerstein G., Yue T.-L., Ma X.L., and Ruffolo Jr. R.R. Carvedilol: a novel multiple action antihypertensive drug that provides major organ protection. Cardiovasc. Drug Rev. 12 (1994) 85-104
18. Folkow B. Physiological aspects of primary hypertension. Physiol. Rev. 62 (1982) 345-504
19. Gellai M., DeWolf R., and Ruffolo Jr. R.R. Effect of carvedilol on renal hemodynamics and renal excretory function in spontaneously hypertensive rats. Pharmacology 41 (1990) 200-206
20. Goldberg L.I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharm. Rev. 24 (1972) 1-29
21. Greven J., and Pantel J. Failure of an angiotensin II antagonist to influence isoprenaline-induced antidiuresis in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 332 (1986) 271-275
22. 1-adrenergic receptors in vascular smooth muscle cells. Am. J. Physiol. 268 (1995) H1006-H1014
23. Hughes J., Beck T., Rose Jr. C.J., and Carey R.M. The effect of selective dopamine-1 stimulation on renal and adrenal function in man. J. Clin. Endocrinol. Metab. 66 (1988) 518-525
24. Hye Khan M.A., Sattar M.A., Abdullah N.A., and Johns E.J. Influence of combined hypertension and renal failure on functional alpha(1)-adrenoceptor subtypes in the rat kidney. Br. J. Pharmacol. 153 (2008) 1232-1241
25. Just A., Wittmann U., Ehmke H., and Kirchheim H.R. Autoregulation of renal blood flow in the conscious dog and the contribution of the tubuloglomerular feedback. J. Physiol. 506 (1998) 275-290
26. 1-adrenoceptor subtype mediating vasoconstriction in the kidney of the rat. Eur. J. Pharmacol. 569 (2007) 110-118
27. 1B-Adrenoceptors mediate adrenergically-induced renal vasoconstrictions in rats with renal impairment. Acta Pharmacol. Sin. 29 (2008) 193-203
28. 1-adrenergic receptors in renal hemodynamics of rats with a combined state of acute renal failure and hypertension. Br. J. Pharmacol. 153 (2008) 1232-1241
29. Li H.T., Long C.S., Gray M.O., Rokosh D.G., Honbo N.Y., and Karliner J.S. Cross talk between angiotensin AT1 and alpha1-adrenergic receptors: angiotensin II down regulates alpha-1 adrenergic receptor subtype mRNA and density in neonatal rat cardiac myocytes. Circ. Res. 81 (1997) 396-403
30. Malpas S.C., and Evans R.G. Do different levels and patterns of sympathetic activation all provoke renal vasoconstriction?. J. Auton. Nerv. Syst. 69 (1998) 72-82
31. Mark A.L., Eckstein J.W., and Abboud F.M. Renal vascular responses to isoproterinol. Am. J. Physiol. 217 (1969) 764-767
32. Moosavi S.M., and Johns E.J. The effect of isoprenaline infusion on renal rennin and angiotensinogen gene expression in the anaesthetized rat. Exp. Physiol. 88 (2003) 221-227
33. Moreau N., Richer C., Vincent M., and Giudicelli J. Interaction between SR 47436, a new angiotensin II antagonist and sympathetic nervous system in pithed SHR rats. Arch. Mal. Coeur. Vaiss. 86 (1993) 1269-1274
34. Münter K., Ehmke H., and Kirchengast M. Maintenance of blood pressure in normotensive dogs by endothelin. Am. J. Physiol. 276 (1999) H1022-H1027
35. Reid I.A. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am. J. Physiol. 262 (1992) E763-E778
36. Rodríguez-Pérez J.C., Losada A., Anabitarte A., Cabrera J., Llobet J., Palop L., and Plaza C. Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats. J. Pharmacol. Exp. Ther. 283 (1997) 336-344
37. Rodríguez-Pérez J.C., Cabrera J.J., Anabitarte A., Plaza M.L., Losada A., García-Suárez P., and Afonso J.L. Effects of carvedilol in rats with induced chronic kidney failure. Nefrologia 21 (2001) 52-58
38. Ruffolo Jr. R.R., Boyle D.A., Brooks D.P., et al. Carvedilol: a novel cardiovascular drug with multiple actions. Cardiovasc. Drug Rev. 10 (1992) 127-147
39. 1-adrenoceptors subtype mediating adrenergic vasoconstriction in Wistar normotensive and stroke-prone spontaneously hypertensive rat kidney. J. Cardiovasc. Pharmacol. 23 (1994) 232-239
40. Sumners C., and Raizada M.K. Angiotensin II receptor subtypes in neuronal cells. In: Raizada M.K., Phillips M.I., and Sumners C. (Eds). Cellular and molecular biology of the renin-angiotensin system (1993), CRC, Boca Raton, FL 379-411
41. Taira N., Yabuuchi Y., and Yamashita S. Profile of beta-adrenoceptors in femoral, superior mesenteric and renal vascular beds of dogs. Br. J. Pharmacol. 59 (1977) 577-583
42. Tomlinson B., Bompart F., Graham B.R., Liu J.-B., and Prichard B.N.C. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine. Drugs 36 (1988) 37-47